Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer

Conditions: Endometrial Neoplasms Interventions: Drug: Tislelizumab; Drug: Paclitaxel; Drug: Carboplatin Sponsors: Zhongnan Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials